Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7418)
All Articles published online
|
Publishing Process of This Article
|
Oct 28, 2019 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wan BS, Cheng M, Zhang L. Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation via activation of AKT and is directly targeted by microRNA-494 in pancreatic cancer. World J Gastroenterol 2019; 25(40): 6063-6076 [PMID: 31686763 DOI: 10.3748/wjg.v25.i40.6063] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v25/i40/6063.htm |
| Number | Citing Articles |
| 1 |
Davide Di Fusco, Maria Teresa Segreto, Giulia Di Maggio, Andrea Iannucci, Claudia Maresca, Antonio Di Grazia, Marco Colella, Carmine Stolfi, Giovanni Monteleone, Ivan Monteleone. Insulin-like Growth Factor II mRNA-Binding Protein 1 Regulates Pancreatic Cancer Cell Growth through the Surveillance of CDC25A mRNA. Cancers 2023; 15(20): 4983 doi: 10.3390/cancers15204983
|
| 2 |
Ammar Sarwar, Bo Wang, Qi Su, Yanmin Zhang. MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer. Biochemical Pharmacology 2021; 189: 114357 doi: 10.1016/j.bcp.2020.114357
|
| 3 |
Liangliang Meng, Xiaoxi He, Xiao Zhang, Xiaobo Zhang, Yingtian Wei, Bin Wu, Jing Li, Yueyong Xiao, Maciej Gagat. Predicting the Clinical Outcome of Lung Adenocarcinoma Using a Novel Gene Pair Signature Related to RNA-Binding Protein. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8896511
|
| 4 |
Xiaoli Xu, Junchen Leng, Xiao Zhang, Terence D. Capellini, Yuan Chen, Liu Yang, Zitong Chen, Shuailong Zheng, Xujia Zhang, Siyuan Zhan, Linjie Wang, Tao Zhong, Jiazhong Guo, Lili Niu, Yan Wang, Dinghui Dai, Hongping Zhang, Li Li, Jiaxue Cao. Identification of IGF2BP1‐related lncRNA‐miRNA‐mRNA network in goat skeletal muscle satellite cells. Animal Science Journal 2021; 92(1) doi: 10.1111/asj.13631
|
| 5 |
Moein Ala. Target c-Myc to treat pancreatic cancer. Cancer Biology & Therapy 2022; 23(1): 34 doi: 10.1080/15384047.2021.2017223
|
| 6 |
Xin Shang, Lan-Er Shi, Dina Taule, Zhang-Zhi Zhu. A Novel miRNA–mRNA Axis Involves in Regulating Transcriptional Disorders in Pancreatic Adenocarcinoma. Cancer Management and Research 2021; : 5989 doi: 10.2147/CMAR.S316935
|
| 7 |
Meiqi Duan, Haiyang Liu, Shasha Xu, Zhi Yang, Fusheng Zhang, Guang Wang, Yutian Wang, Shan Zhao, Xiaofeng Jiang. IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment. Genes & Diseases 2024; 11(2): 890 doi: 10.1016/j.gendis.2023.06.017
|
| 8 |
Hu Tuo, Baozhen Yao, Bing He, Shiqian Yu, Danni Li, Wenjing Li, Lin Jin. Silence of Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 Prevents Vascular Smooth Muscle Cells Proliferation via Nuclear Factor of Activated T Cells Isoform-3/Ca2+/Calmodulin Pathway. Journal of Biomaterials and Tissue Engineering 2021; 11(4): 704 doi: 10.1166/jbt.2021.2747
|
| 9 |
Shuangping Ma, Yiran Qin, Wenjie Ren. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in hematological diseases. Molecular Medicine 2024; 30(1) doi: 10.1186/s10020-024-00936-2
|
| 10 |
Zhiqi Zhang, Haitao Yu, Wenyan Yao, Na Zhu, Ran Miao, Zhiquan Liu, Xuwei Song, Chunhua Xue, Cheng Cai, Ming Cheng, Ke Lin, Dachuan Qi. RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway. Cell Communication and Signaling 2022; 20(1) doi: 10.1186/s12964-022-00974-5
|
| 11 |
Ekene Nweke, Martin Brand. Downregulation of the let‑7 family of microRNAs may promote insulin receptor/insulin‑like growth factor signalling pathways in pancreatic ductal adenocarcinoma. Oncology Letters 2020; 20(3): 2613 doi: 10.3892/ol.2020.11854
|
| 12 |
Peng-Fei Wang, Xiaoyu Wang, Min Liu, Zheng Zeng, Caiji Lin, Wenwen Xu, Wenqing Ma, Jiali Wang, Qian Xiang, Randal N. Johnston, Huidi Liu, Shu-Lin Liu. The Oncogenic Functions of Insulin-like Growth Factor 2 mRNA-Binding Protein 3 in Human Carcinomas. Current Pharmaceutical Design 2020; 26(32): 3939 doi: 10.2174/1381612826666200413080936
|
| 13 |
Yuanqian Cai, Yingzhe Wang, Bingjie Mao, Qidong You, Xiaoke Guo. Targeting insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs) for the treatment of cancer. European Journal of Medicinal Chemistry 2024; 268: 116241 doi: 10.1016/j.ejmech.2024.116241
|
| 14 |
Wen Fu, Xianxing Wang, Jifeng Xiang, Shengkai Chen, Renpei Xia, Fuming Xie, Bojing Chi, Fanbo Qin, Zhuo Li, Li Mou, Chuanming Xie, Huaizhi Wang. CircPTPRA promotes the progression of pancreatic ductal adenocarcinoma via the miR‐140‐5p/LMNB1 axis. Cancer Medicine 2023; 12(10): 11651 doi: 10.1002/cam4.5869
|
| 15 |
Nitin Patil, Omar G. Abdelrahim, Jörg H. Leupold, Heike Allgayer. JAK1 Is a Novel Target of Tumor- and Invasion-Suppressive microRNA 494-5p in Colorectal Cancer. Cancers 2023; 16(1): 24 doi: 10.3390/cancers16010024
|
| 16 |
Yuhao Zhao, Mao Yang, Shijia Wang, Sk Jahir Abbas, Junzhe Zhang, Yongsheng Li, Rong Shao, Yingbin Liu. An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.854773
|
| 17 |
Asghar Ali, Mark Stenglein, Thomas Spencer, Gerrit Bouma, Russell Anthony, Quinton Winger. Trophectoderm-Specific Knockdown of LIN28 Decreases Expression of Genes Necessary for Cell Proliferation and Reduces Elongation of Sheep Conceptus. International Journal of Molecular Sciences 2020; 21(7): 2549 doi: 10.3390/ijms21072549
|
| 18 |
Fatemeh Katoozian, Zahra Abedi Kichi, Roya Sharifi, Zeinab Shirvani-Farsani. The Expression Analysis of Long Non-coding RNAs Related to Wnt/β-Catenin Signaling in Pancreatic Cancer Patients. Biochemical Genetics 2024; doi: 10.1007/s10528-024-10779-5
|
| 19 |
Sai Chen, Hefei Ren, Xiaomin Zhang, Liu Chang, Zhenhua Wang, Hongkun Wu, Jiafeng Zhang, Jigang Ren, Lin Zhou. Research advances of N6‐methyladenosine in diagnosis and therapy of pancreatic cancer. Journal of Clinical Laboratory Analysis 2022; 36(9) doi: 10.1002/jcla.24611
|
| 20 |
Wenwen Wang, Wenwen Zhang, Yuanjing Hu. Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer. PeerJ 2021; 9: e12353 doi: 10.7717/peerj.12353
|
| 21 |
Nannan Yang, Lin Liu, Xiaoyu Liu, Yingjie Chen, Jian Lu, Zhongmin Wang, Wen Shi. hnRNPC Promotes Malignancy in Pancreatic Cancer through Stabilization of IQGAP3. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6319685
|
| 22 |
Wen-Liang Zhan, Ning Gao, Guo-Long Tu, Hong Tang, Ling Gao, Ying Xia. LncRNA LINC00689 Promotes the Tumorigenesis of Glioma via Mediation of miR-526b-3p/IGF2BP1 Axis. NeuroMolecular Medicine 2021; 23(3): 383 doi: 10.1007/s12017-020-08635-x
|
| 23 |
Peng Liu, Peng Zhao, Bing Li, Dianxiang Xu, Kun Wang. LncRNA PCAT6 Regulated by YY1 Accelerates the Progression of Glioblastoma via miR-513/IGF2BP1. Neurochemical Research 2020; 45(12): 2894 doi: 10.1007/s11064-020-03138-4
|
| 24 |
Xiaoge Hu, Xiangxiang Lei, Jinhui Guo, Wen Fu, Wen Sun, Qiliang Lu, Wei Su, Qiuran Xu, Kangsheng Tu. The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.927640
|
| 25 |
Panpan Feng, Dawei Chen, Xia Wang, Yanxia Li, Zhenyu Li, Boya Li, Yupeng Zhang, Wei Li, Jingru Zhang, Jingjing Ye, Baobing Zhao, Jingxin Li, Chunyan Ji. Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia 2022; 36(9): 2180 doi: 10.1038/s41375-022-01651-9
|
| 26 |
Xudong Yang, Jisheng Liu. Targeting PD-L1 (Programmed death-ligand 1) and inhibiting the expression of IGF2BP2 (Insulin-like growth factor 2 mRNA-binding protein 2) affect the proliferation and apoptosis of hypopharyngeal carcinoma cells. Bioengineered 2021; 12(1): 7755 doi: 10.1080/21655979.2021.1983278
|
| 27 |
Markus Glaß, Patrick Michl, Stefan Hüttelmaier. RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2020; 21(11): 4190 doi: 10.3390/ijms21114190
|